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See related research by Tie et al., http://ccforum.com/content/18/5/517The systematic review and meta-analysis of prospective
randomized trials reported by Tie and colleagues [1] in a
previous issue of Critical Care provide evidence that
intravenous sodium bicarbonate (SBIC) administration does
not reduce the incidence of cardiac surgery-associated
(CSA) acute kidney injury (AKI) but prolongs the duration
of mechanical ventilation and of hospital stay.
The conclusions of the authors are corroborated by a
recent comprehensive systematic review [2] demonstrating
that the administration of SBIC to patients at risk for
CSA-AKI, contrast-induced nephropathy, septic AKI,
or pigment nephropathy has no additional benefit
compared with saline but adds to in-hospital morbidity
and mortality.
The authors do not discuss the mechanisms underlying
possible harms of SBIC. In cardiac patients, this type of fluid
may precipitate volume overload and acute pulmonary
edema. Alkalosis-induced hypoventilation may be associated
with myocardial ischemia aggravating decreased cardiac
contractility and may cause arrhythmia by inducing
hypokalemia [3,4].
The principal intervention with proven efficacy for
the prevention of AKI is adequate fluid administration.
Definitively, SBIC is not the optimal fluid.Authors’ response
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We appreciate Schiffl’s insightful commentary, which
encourages us to expand on the mechanisms of SBIC in
the prevention of CSA-AKI.
The inefficacy of SBIC was due to the hypothesis that
the significant increased power of hydrogen (PH) might
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unless otherwise stated.could cause possible harms. Firstly, arrhythmia and
hypoventilation via inducing hypokalemia and alkalosis
impair the cardiac function, as indicated by Schiffl.
Moreover, hypocapnia by inducing alkalosis could reduce
the cerebral blood flow and result in seizures and even
coma or death [5]. Secondly, SBIC administration could
impair the oxygenation and subsequently exacerbate the
ischemia-reperfusion injury by aggravating the ischemia [4].
Thirdly, the induced intracellular alkalinization is associated
with increased cell death, cell apoptosis, superoxide
formation, pro-inflammatory cytokine release, blood
lactate, and ketone bodies [6]. Finally, SBIC could cause
decreased arterial blood pressure [7], an emergency
situation for patients after cardiac surgery. Therefore, the
risks overwhelm the benefits of SBIC for CSA-AKI
prevention in patients undergoing cardiac surgery.
However, the hypothesis that SBIC administration may
precipitate volume overload and acute pulmonary edema
seems irrational because each patient received the same
solution (for example, 5% dextrose) and the same amount
of fluid volume in each study. In short, the possible harms
of SBIC should not be attributed to volume overload and
acute pulmonary edema.
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